CureVac

Health
Tesla and Curevac have developed a vaccine printer
Tesla and Curevac have developed a vaccine printer
Credit: Screenshot via Twitter

Already in June 2019 the German biotech company Curevac and Tesla subsidiary Grohmann have applied for a patent for a newly developed vaccination printer.

A newly developed mobile "RNA Printer" is able to produce over a hundred thousand vaccination dosages in a few weeks. Originally developed to combat diseases like rabies and yellow fever it could potentially be used to produce a future Covid-19 vaccine given the approval for medical use of the printer and a vaccine.

Regional News • Americas • United States
German Health Ministry confirmed: Trump tried to buy German research company to make potential Covid-19 vaccine US exclusive

Following a meeting at the White House with representatives from pharmaceutical companies, Donald Trump, Mike Pence and other members of the US's coronavirus task force to discuss the development of a vaccine against Covid-19, Donald Trump tried to buy the German research company CureVac. Trump had intended to make the vaccine "for the U.S. only", according to the German newspaper "Die Welt". The German Health Ministry confirmed that the reporting from "Die Welt" was accurate and Germany itself is now offering financial incentives for the company in order to stay in Germany.